WW price target raised to $12.50 from $11 at DA Davidson

DA Davidson analyst Linda Bolton Weiser raised the firm’s price target on WW to $12.50 from $11 and keeps a Buy rating on the shares. The analyst cites the company’s Q2 operating profit upside, even though its sales missed estimates on a mix shift toward digital. WW should be “ideally positioned” in an scenario where the standard of care will be a step program model, with lifestyle changes required before insurance coverage of drugs, the firm tells investors in a research note.